Dow Jones

40,003.59

0.34%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

PAIC

Petra Acquisition (PAIC)

Petra Acquisition Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PAIC

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
29/06/2023	15:24	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PAIC	Petra Acquisition Inc
15/06/2023	15:51	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PAIC	Petra Acquisition Inc
22/05/2023	05:32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PAIC	Petra Acquisition Inc
15/05/2023	16:35	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:PAIC	Petra Acquisition Inc
18/04/2023	15:09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PAIC	Petra Acquisition Inc
30/03/2023	15:52	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PAIC	Petra Acquisition Inc
21/02/2023	15:50	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PAIC	Petra Acquisition Inc
14/02/2023	11:29	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:PAIC	Petra Acquisition Inc
10/02/2023	05:09	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PAIC	Petra Acquisition Inc
09/02/2023	08:38	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-1mef)	NASDAQ:PAIC	Petra Acquisition Inc
01/02/2023	15:10	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:PAIC	Petra Acquisition Inc
13/01/2023	15:21	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:PAIC	Petra Acquisition Inc
20/12/2022	15:18	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:PAIC	Petra Acquisition Inc
29/11/2022	05:05	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:PAIC	Petra Acquisition Inc
31/05/2022	16:23	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PAIC	Petra Acquisition Inc
22/04/2022	16:22	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:PAIC	Petra Acquisition Inc
10/03/2022	15:04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PAIC	Petra Acquisition Inc
15/02/2022	05:46	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:PAIC	Petra Acquisition Inc
09/02/2022	15:26	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:PAIC	Petra Acquisition Inc
20/01/2022	17:07	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PAIC	Petra Acquisition Inc
22/12/2021	08:00	GlobeNewswire Inc.	Petra Acquisition, Inc. Announces Share Redemption Backstop and Forward Purchase Agreements in Connection with Revelation Biosciences, Inc. Business Combination	NASDAQ:PAIC	Petra Acquisition Inc
16/12/2021	15:15	GlobeNewswire Inc.	Petra Acquisition, Inc. Announces Special Meeting of Stockholders to Approve Business Combination with Revelation Biosciences, Inc.	NASDAQ:PAIC	Petra Acquisition Inc
16/12/2021	15:06	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:PAIC	Petra Acquisition Inc
13/12/2021	15:26	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:PAIC	Petra Acquisition Inc
06/12/2021	15:01	GlobeNewswire Inc.	Revelation Biosciences Inc. Appoints Joseph A. Bellanti, M.D. to Scientific Advisory Board	NASDAQ:PAIC	Petra Acquisition Inc
01/12/2021	15:01	GlobeNewswire Inc.	Revelation Biosciences Inc. Announces Initiation of a Phase 2b Study to Assess Efficacy of Intranasal REVTx-99 for The Prevention of H3N2 Influenza	NASDAQ:PAIC	Petra Acquisition Inc
29/11/2021	08:00	GlobeNewswire Inc.	Revelation Biosciences Inc. Announces Creation and Appointments to Scientific Advisory Board	NASDAQ:PAIC	Petra Acquisition Inc
15/11/2021	08:00	GlobeNewswire Inc.	Revelation Biosciences Inc. Announces Initiation of a Phase 1b Clinical Study of REVTx-99 for the Experimental Treatment of Allergic Rhinitis and Chronic Nasal Congestion	NASDAQ:PAIC	Petra Acquisition Inc
01/11/2021	09:14	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PAIC	Petra Acquisition Inc
01/11/2021	08:00	GlobeNewswire Inc.	Revelation Biosciences Inc. Engages Partnering Advisor, MedWorld Advisors, to Optimize Value of the Company’s Diagnostic Tool, REVID™	NASDAQ:PAIC	Petra Acquisition Inc